Search
Search Results
-
A novel alectinib-sensitive CTNND1-ALK fusion in a lung adenocarcinoma patient: a case report
Genomic fusions of anaplastic lymphoma kinase ( ALK ) are a well-established therapeutic target in non-small-cell lung cancer (NSCLC). Although various ALK...